MS in Latin America

International MS Journal

Volumn 15, Issue 1, 2008, Pages 3-5

  Correole, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR ALPHA;

AUTOIMMUNE DISEASE; CAUCASIAN; CLINICAL TRIAL; DISEASE ACTIVITY; DOSE RESPONSE; EDITORIAL; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HISTOCOMPATIBILITY COMPLEX; HUMAN; IMMIGRATION; INCIDENCE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHARMACOGENETICS; PHARMACOGENOMICS; PREVALENCE; SOUTH AND CENTRAL AMERICA; SUPPORT GROUP;

HUMANS; LATIN AMERICA; MULTIPLE SCLEROSIS;

EID: 51649113967     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (35)

1. Luetic G. MS in Latin America. Int MS J 2008; 15: 6-11.
2. Sospedra M, Martín R. Immunology of multiple sclerosis. Annu Rev Immunol 2005; 23: 683-747.
3. Poser CM. An atlas of multiple sclerosis. In: Multiple Sclerosis. (Poser CM, ed). New York: Parthenon Publishing Group 1998; pp16-18.
4. Kurtzke JF. Epidemiology and etiology of multiple sclerosis. Phys Med Rehabil Clin N Am 2005; 16: 327-349.
5. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001; 22: 117-139.
6. Gonzalez O, Sotelo J. Is the frequency of multiple sclerosis increasing in Mexico? J Neurol Neurosurg Psychiatry 1995; 59: 528-530.
7. Callegaro D, de Lolio CA, Rodvany J, et al. Prevalence of multiple sclerosis in the city of São Paulo, Brazil, in 1990. Neuroepidemiology 1992; 11: 11-14.
8. Callegaro D, Goldbaum M, Morais L, Tilbery CP, Moreira MA, Gabbai et al. The prevalence of multiple sclerosis in the city of São Paulo, Brazil, in 1997. Acta Neurol Scand 2001; 104: 208-213.
9. Corona T, Román GC. Multiple Sclerosis in Latin America. Neuroepidemiology 2006; 26: 1-3.
10. Rivera VM, Landero S. Multiple Sclerosis in Mexican American population. Int J MS Care 2005/6; 7: 143-147.
11. Rivera VM, Cabrera Gómez JA. La esclerosis múltiple en Latinoamérica. Médica Interam 2000; 19: 458-467.
12. Kurtzke JF, Kurland LT, Goldberg ID, Choi NW. Multiple Sclerosis. In: Epidemiology of neurologic and sense organ disorders. (Kurland LT, Kurtzke JF, Goldberg ID, eds). Cambridge: Harvard University 1973; pp604-607.
13. Ebers GC, Sadovnick AD. The geographic distribution of multiple sclerosis: a review. Neuroepidemiology 1993; 12: 1-5.
14. Rosati G. Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: a critical overview. Ann Neurol 1994; 36 (Suppl 2): S164-S174.
15. Melcon MO, Gold L, Carrá A et al. Multiple Sclerosis in the Argentine Patagonia: lack of a latitude gradient. Neurology 2004; 62: A219.
16. Dyment DA, Ebers GA, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol 2004; 3: 104-110.
17. The International Multiple Sclerosis Genetics Consortium, Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL et al. Risk alleles for multiple sclerosis identified by a genome wide study. New Engl J Med 2007; 357: 851-862.
18. Alvarado de Barrera C, Zuñiga-Ramos J, Ruiz-Morales JA, Estañol B, Granados J, Llorente L. HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis. Neurology 2000; 55: 1897-1990.
19. Kotsyu DD, Amos DB. Mysteries of the Amerindians. Tissue Antigens 1981; 17: 111-123.
20. Godorezky C, Castro Escobar LE, Escobar Gutierrez A. HLA system in the prevalent Mexican Indian Group: the Nahuas. Tissue Antigens 1985; 25: 38-46.
21. Mirsattari SM, Johnston JB, McKenna R, et al. Aboriginals with multiple sclerosis. HLA types and predominance of neuromyelitis optica. Neurology 2001; 56: 317-323.
22. Kira J. Multiple Sclerosis in the Japanese population. Lancet Neurol 2003; 2: 117-127.
23. Alves-Leon SV, Papais-Alvarenga R, Magalhães M, Alvarenga M, Thuler LC, Fernández y Fernández O. Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients. Acta Neurol Scand 2007; 115: 306-311.
24. Cordova J, Vargas S, Sotelo J. Western and Asian features of multiple sclerosis in Mexican Mestízos. Clin Neurol Neurosurg 2007; 109: 146-151.
25. Suarez-Kurtz G, Pena SDJ. Pharmacogenomics in the Americas: The impact of genetic admixture. Curr Drug Targets 2006; 7:1649-1658.
26. Suarez-Kurtz G. Pharmacogenomics in admixed populations. Trends Pharmacol Sci 2005; 26: 196-201.
27. Cree BAC, Al-Sabbagh A, Bennett R, Goodin D. Response to Interferon beta-1a treatment in African American Multiple Sclerosis patients. Arch Neurol 2005; 62: 1681-1683.
28. Fleming JO, Cook TD. Multiple Sclerosis and the hygiene hypothesis. Neurology 2006; 67: 2085-2086.
29. Correale J, Farez M. Parasite infections modulate the immune response in multiple sclerosis. Ann Neurol 2007; 61: 97-108.
30. Cabre P, Signate A, Olindo S, Merle H, Caparros-Lefebvre, Béra O et al. Role of return migration in the emergence of multiple sclerosis in the French West Indians. Brain 2005; 128: 2899-2910.
31. Cardoso E, Fukuda T, Pereira J, Seixas J, Miranda R, Rodrigues B et al. Clinical and epidemiological profile of multiple sclerosis in a reference center in the state of Bahia, Brazil. Arq Neuropsiquiatr 2006; 64: 727-730.
32. Cree BAC, Khan O, Bourdette D, Goodin GS, Cohen JA, Marrie RA et al. Clinical characteristics of African American vs Caucasian Americans with multiple sclerosis. Neurology 2004; 63: 2039-2045.
33. Lana-Peixoto MA, Lana-Peixoto MIV. Is multiple sclerosis in Brazil and Asia alike? Arq Neuropsiquiatr 1992; 50: 419-425.
34. Papais-Alvarenga RM, Miranda-Santos CM. Puccioni-Sohler M, de Almeida AM, Oliveira S, Basilio De Oliveira CA et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 2002; 73: 429-435.
35. Patrucco LB, Cristiano E, Videla GC, et al. Devic's neuromyelitis optica (NMO) and Multiple Sclerosis (MS); clinical and epidemiological findings in a MS Center in Argentina. Mult Scler 2002; 8 (Suppl): 51.